Health Insurance News and Research

RSS

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Patients with plaque build-up in their arteries, who suffered a transient ischemic attack (TIA) or a minor ischemic stroke, also called a warning stroke, and were treated with the newer blood thinner ticagrelor plus aspirin were 27% less likely to have another stroke within 30 days, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Even when risk factors associated with cardiovascular disease are optimally controlled, adults with Type 2 diabetes still have a greater risk of developing cardiovascular disease compared to the general population, according to new research published today in the American Heart Association's flagship journal Circulation.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women who had no major artery blockage, according to late- breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

‘An Arm and a Leg’: For your next health insurance fight, an exercise in financial self-defense

A listener asked: 'How do I remain cool when calling insurance companies?" So we called veteran self-defense teacher Lauren Taylor for advice. She leads Defend Yourself, an organization that works to empower people against violence and abuse.

16 Nov 2020

Red states’ case against ACA hinges on whether they were actually harmed by the lawc

Attorneys for GOP-controlled states seeking to kill the Affordable Care Act told the Supreme Court last week that at least some of the 12 million people who newly enrolled in Medicaid signed up only because of the law's requirement that people have insurance coverage — although a tax penalty no longer exists.

16 Nov 2020

Long-term care workers, grieving and under siege, brace for COVID’s next round

In the middle of the night, Stefania Silvestri lies in bed remembering her elderly patients' cries.

16 Nov 2020

New screening strategy can help identify individuals with higher probability of developing heart disease

More than 40% of middle-aged adults have silent coronary artery disease. Researchers have developed a new screening questionnaire to help identify individuals at the highest risk for coronary artery disease, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

A single, daily pill combining blood pressure and cholesterol medications, along with the addition of a daily dose of aspirin, reduced cardiovascular disease events in people at risk for heart disease, according to late-breaking research presented today in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Taking omega-3 fatty acids and vitamin D3 supplements does not neither increase nor decrease the risk of developing atrial fibrillation, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Patients who were hospitalized with acute heart failure and had iron deficiency were less likely to return to the hospital if given intravenous iron replacement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

15 Nov 2020

Weekly exercise linked to lower risk of Alzheimer's disease in patients with mild cognitive impairment

Exercising more than once per week is associated with a lower risk of developing Alzheimer's disease in patients with mild cognitive impairment, research published in the open access journal Alzheimer's Research and Therapy suggests.

12 Nov 2020

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Drugmaker Pfizer is expected to seek federal permission to release its COVID-19 vaccine by the end of November, a move that holds promise for quelling the pandemic, but also sets up a tight time frame for making sure consumers understand what it will mean to actually get the shots.

12 Nov 2020

Workers who lost jobs due to COVID may need help getting coverage this fall

Michelina Moen lost her job and health insurance in April. Only weeks earlier she had begun to feel ill and not her usual energetic self — in what she describes as a textbook case of "really bad timing."

12 Nov 2020

Health Insurance News and Research

Combination of ticagrelor and aspirin reduces subsequent stroke risk in patients with heart plaque

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

‘An Arm and a Leg’: For your next health insurance fight, an exercise in financial self-defense

Red states’ case against ACA hinges on whether they were actually harmed by the lawc

Long-term care workers, grieving and under siege, brace for COVID’s next round

New screening strategy can help identify individuals with higher probability of developing heart disease

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Weekly exercise linked to lower risk of Alzheimer's disease in patients with mild cognitive impairment

Time to discuss potentially unpleasant side effects of COVID shots? Scientists say yes.

Workers who lost jobs due to COVID may need help getting coverage this fall

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News